Antibody-Based Imaging and Therapy for Precision Medicine

Weijun Wei¹, Dawei Jiang^{2

3

4}, Laura Evangelista⁵, Weibo Cai⁶

Affiliations

¹ Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
² Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China.
³ Hubei Key Laboratory of Molecular Imaging, Wuhan 430022, Hubei, China.
⁴ Key Laboratory of Biological Targeted Therapy, Ministry of Education, Wuhan 430022, China.
⁵ Nuclear Medicine Unit, Department of Medicine - DIMED, University of Padua, Padua 35122, Italy.
⁶ Departments of Radiology and Medical Physics, University of Wisconsin-Madison Madison, Wisconsin 53705, United States.

Editorial

Weijun Wei et al. Mol Pharm. 2022.

. 2022 Oct 3;19(10):3453-3455.

doi: 10.1021/acs.molpharmaceut.2c00606.

Weijun Wei¹, Dawei Jiang^{2

3

4}, Laura Evangelista⁵, Weibo Cai⁶

¹ Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
² Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China.
³ Hubei Key Laboratory of Molecular Imaging, Wuhan 430022, Hubei, China.
⁴ Key Laboratory of Biological Targeted Therapy, Ministry of Education, Wuhan 430022, China.
⁵ Nuclear Medicine Unit, Department of Medicine - DIMED, University of Padua, Padua 35122, Italy.
⁶ Departments of Radiology and Medical Physics, University of Wisconsin-Madison Madison, Wisconsin 53705, United States.

No abstract available

Publication types